Literature DB >> 411874

Genetic control of cell-mediated responsiveness to an AKR tumor-associated antigen: mapping of the locus involved to the I region of the H-2 complex.

D Meruelo, B Deak, H O McDevitt.   

Abstract

The role of H-2-linked genes in controlling resistance to murine leukemia viruses has been studied by measuring the cell-mediated immune response of F1 hybrid mice (between AKR and various C3H and C57BL/10 derived, H-2 congenic strains) to an AKR tumor cell line, BW5147. The studies have shown that the ability to generate a primary or secondary cell-mediated response to an AKR tumor cell antigenic determinant is under H-2 linked control. The locus determining CML responsiveness maps in the I-J subregion. Nonresponsiveness is associated with the H-2q/k and H-2b/k hybrid genotypes, whereas responsiveness is associated with the H-2k/k homozygous genotype. Nonresponsiveness may result from (a) dominant suppression; (b) recessive responsiveness; or (c) an alternate mechanism not yet understood. This type of control may be one of several H-2-associated mechanisms of defense against virus-induced neoplasms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 411874      PMCID: PMC2180965          DOI: 10.1084/jem.146.5.1367

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

Review 1.  Protein clinical manifestations of primary tumors of the heart.

Authors:  H O McDevitt; W F Bodmer
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

Review 2.  Histocompatibility-linked genetic control of specific immune responses to viral infection.

Authors:  H O McDevitt; B A Oldstone; T Pincus
Journal:  Transplant Rev       Date:  1974

Review 3.  Histocompatibility-linked immune response genes.

Authors:  B Benacerraf; H O McDevitt
Journal:  Science       Date:  1972-01-21       Impact factor: 47.728

4.  The H-2 locus and viral leukemogenesis as studied in congenic strains of mice.

Authors:  J R Tennant; G D Snell
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

5.  The role of genetics in Gross virus leukemogenesis.

Authors:  F Lilly
Journal:  Bibl Haematol       Date:  1970

6.  Genetic control of natural immunity to ecotropic mouse leukemia viruses: immune response genes.

Authors:  R C Nowinski
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

7.  Genetic control of radiation leukemia virus-induced tumorigenesis. I. Role of the major murine histocompatibility complex, H-2.

Authors:  D Meruelo; M Leiberman; N Ginzton; B Deak; H O McDevitt
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

8.  Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex.

Authors:  B Chesebro; K Wehrly; J Stimpfling
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

9.  Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT).

Authors:  J A Kapp; C W Pierce; S Schlossman; B Benacerraf
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.

Authors:  H Sato; E A Boyse; T Aoki; C Iritani; L J Old
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  11 in total

1.  Genetic control of responsiveness to the tumor-associated transplantation antigen of a chemically induced murine fibrosarcoma.

Authors:  G Parmiani
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

Review 2.  Role of the major histocompatibility complex in resistance to viral leukemia; its effect on the preleukemic stage of leukemogenesis.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Springer Semin Immunopathol       Date:  1982

3.  I-region linked complementing loci in resistance to viral leukemogenesis in the mouse.

Authors:  P Lonai; E Katz; N Haran-Ghera
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

4.  The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.

Authors:  W R Green; R C Nowinski; C S Henney
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

5.  In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia.

Authors:  D Meruelo; N Flieger; D Smith; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  HLA and adult T cell leukaemia: HLA-linked genes controlling susceptibility to human T cell leukaemia virus type I.

Authors:  H Uno; K Kawano; H Matsuoka; K Tsuda
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

7.  H-21-linked control of immunological resistance to viral leukemogenesis as a response to preleukemic cells.

Authors:  P Lonai; E Katz; A Peled; N Haran-Ghera
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

8.  Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes.

Authors:  L A Sherman
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

9.  A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.

Authors:  D Meruelo
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

10.  I-J restrictions on the activation and interaction of parental and F1-derived TS3 suppressor cells.

Authors:  M Minami; S Furusawa; M E Dorf
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.